Sign in
ZYBT Stock Price, Chart, Stats & News
Zhengye Biotechnology Holding Limited
Save
Zhengye Biotechnology Holding Limited (ZYBT) does not currently pay a dividend.
62.08M
Market cap
–
Current P/E
–
Forward P/E
ZYBT chart
Fundamentals
Gross margin | 48.99% |
Operating margin | 8.82% |
Pretax margin | 7.72% |
Net margin | 6.07% |
Effective tax rate | 6.42% |
ROA | 2.29% |
ROE | 4.06% |
D/E | 0.30x |
Interest coverage ratio | 4.07x |
ZYBT valuation
P/E | – |
P/S | 1.48x |
P/B | – |
P/CF | – |
P/FCF | 20.80x |
P/OCF | – |
PEG | – |
EV multiple | 4.89x |
About
Zhengye Biotechnology Holding Limited specializes in the creation, manufacturing, and commercialization of animal health immunizations. The company primarily supplies the Chinese agricultural sector with vaccines tailored for a broad spectrum of farm animals, including swine, bovines, goats, ovines, and poultry. Additionally, its product range encompasses inoculations for canines.
Similar securities
Based on sector and market capitalization
Report issue